UFP Technologies, Inc. (NASDAQ: UFPT) is a Healthcare company in the Medical - Devices industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.
| Index | - | P/E | 29.85 | EPS (ttm) | 9.27 | Insider Own | 11.08% | Shs Outstand | 7.74M | Perf Week | -0.43% |
| Market Cap | 2.14B | Forward P/E | 25.50 | EPS next Y | 10.85 | Insider Trans | -5.14% | Shs Float | 7.43M | Perf Month | -11.56% |
| Enterprise Value | 2.26B | PEG | 2.06 | EPS next Q | 2.63 | Inst Own | - | Short Float | 14.18% | Perf Quarter | 15.63% |
| Income | 72.00M | P/S | 3.39 | EPS this Y | 5.10% | Inst Trans | - | Short Ratio | 5.39 | Perf Half Y | 40.47% |
| Sales | 632.00M | P/B | 4.63 | EPS next Y | 11.37% | ROA | 10.60% | Short Interest | 1.05M | Perf YTD | 24.62% |
| Book/sh | 59.71 | P/C | - | EPS next 5Y | 14.49% | ROE | 16.72% | 52W High | 338.71 -18.31% | Perf Year | 35.00% |
| Cash/sh | 1.16 | P/FCF | 35.00 | EPS past 3/5Y | 17.18% 37.72% | ROIC | 12.65% | 52W Low | 173.85 59.15% | Perf 3Y | 77.99% |
| Dividend Est. | - | EV/EBITDA | 19.68 | Sales past 3/5Y | 19.43% 27.49% | Gross Margin | 28.50% | Volatility | 2.44% 2.75% | Perf 5Y | 316.08% |
| Dividend TTM | - | EV/Sales | 3.58 | EPS Y/Y TTM | 22.30% | Oper. Margin | 15.25% | ATR (14) | 8.71 | Perf 10Y | 925.54% |
| Dividend Ex-Date | - | Quick Ratio | 1.72 | Sales Y/Y TTM | 25.40% | Profit Margin | 11.45% | RSI (14) | 39.95 | Recom | 2.00 |
| Dividend Gr. 3/5Y | - | Current Ratio | 3.00 | EPS Q/Q | 7.60% | SMA20 | -4.31% | Beta | 1.04 | Target Price | 298.00 |
| Payout | 0.00% | Debt/Eq | 0.35 | Sales Q/Q | 15.23% | SMA50 | -2.01% | Rel Volume | 0.82 | Prev Close | 275.41 |
| Employees | 4,846 | LT Debt/Eq | 0.32 | Earnings | Nov 02 | SMA200 | 15.34% | Avg Volume | 175.89K | Price | 276.69 |
| IPO Date | Dec 17, 1993 | Option/Short | Yes / Yes | EPS/Sales Surpr. | 16.70% 9.15% | Net Debt/EBITDA | 1.10 | Volume | 143,763 | Change | 0.46% |
| Date | Action | Analyst | Rating | Target |
|---|---|---|---|---|
| May-07-25 | Reiterated | Lake Street | Buy | $392 → $252 |
| Jul-17-24 | Reiterated | Lake Street | Buy | $270 → $392 |
| Jul-02-24 | Reiterated | Loop Capital Markets | $300 → $344 | |
| Jun-28-24 | Reiterated | Loop Capital Markets | $231 → $300 | |
| May-02-24 | Reiterated | Lake Street | Buy | $231 → $270 |
| Apr-12-24 | Reiterated | Loop Capital Markets | $231 |
UFP Technologies, Inc. specializes in the engineering and custom fabrication of components, subassemblies, finished products, and packaging, primarily utilizing advanced foams, films, and plastics. A significant portion of its business is dedicated to the medical sector, where its single-use and single-patient devices and parts are integral to a broad spectrum of applications, including general medical devices, disposable wound care, infection control, minimally invasive surgical tools, wearable technologies, orthopedic soft goods, and protective packaging for orthopedic implants. Beyond healthcare, the company extends its expertise to the automotive, aerospace and defense, consumer, electronics, and industrial markets. Here, its engineered products and components are incorporated into diverse items such as military uniform and gear, automotive interior trim, athletic padding, sustainable protective packaging, air filtration systems, abrasive nail files, and custom protective cases and inserts. UFP Technologies markets and distributes its offerings across the United States, predominantly through a direct sales force supported by independent manufacturer representatives. The company, established in 1963, is headquartered in Newburyport, Massachusetts.
Per-holder 13F data hasn't been ingested for this ticker yet.
| Line Item (USD, M) | TTM — | FY 2025 12/31/2025 | FY 2024 12/31/2024 | FY 2023 12/31/2023 | FY 2022 12/31/2022 | FY 2021 12/31/2021 | FY 2020 12/31/2020 | FY 2019 12/31/2019 | FY 2018 12/31/2018 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 632 | 603 | 504 | — | — | — | — | — | — | |
| Cost of Goods Sold Incl. D&A | 452 | 432 | 358 | — | — | — | — | — | — | |
| Gross Profit | 180 | 170 | 147 | — | — | — | — | — | — | |
| Selling, General and Administrative Excl. Other | 84 | 77 | 62 | — | — | — | — | — | — | |
| Research and Development | 0 | 0 | 0 | — | — | — | — | — | — | |
| Other Operating Expense | -1 | 1 | 4 | — | — | — | — | — | — | |
| Operating Income | 96 | 92 | 81 | — | — | — | — | — | — | |
| Interest Expense | 8 | 10 | 8 | — | — | — | — | — | — | |
| Unusual Expense | — | — | — | — | — | — | — | — | — | |
| Non-Operating Income (Expense) | 0 | 0 | 0 | — | — | — | — | — | — | |
| Net Income Before Taxes | 89 | 83 | 73 | — | — | — | — | — | — | |
| Income Taxes | 17 | 14 | 14 | — | — | — | — | — | — | |
| Consolidated Net Income | 72 | 68 | 59 | — | — | — | — | — | — | |
| Net Income From Continuing Operations | 72 | 68 | 59 | — | — | — | — | — | — | |
| Net Income | 72 | 68 | 59 | — | — | — | — | — | — | |
| EPS (Recurring) | 9.36 | 8.87 | 7.69 | — | — | — | — | — | — | |
| EPS (Basic, Before Extraordinaries) | 9.36 | 8.87 | 7.69 | — | — | — | — | — | — | |
| EPS (Diluted) | 9.27 | 8.77 | 7.58 | — | — | — | — | — | — | |
| EBITDA | 115 | 116 | 96 | — | — | — | — | — | — | |
| Other After Tax Adjustments | — | — | — | — | — | — | — | — | — | |
| Stock Option Compensation Expense | — | — | — | — | — | — | — | — | — | |
| Price To Earnings Ratio | 29.85 | 25.32 | 32.26 | — | — | — | — | — | — | |
| Price To Sales Ratio | 3.50 | 2.95 | 3.88 | — | — | — | — | — | — | |
| Gross Margin | 28.48 | 28.19 | 29.17 | — | — | — | — | — | — | |
| Operating Margin | 15.19 | 15.26 | 16.07 | — | — | — | — | — | — | |
| Net Margin | 11.39 | 11.28 | 11.71 | — | — | — | — | — | — | |
| Shares Outstanding | 8 | 8 | 8 | — | — | — | — | — | — | |
| Market Capitalization | 2,214 | 1,776 | 1,956 | — | — | — | — | — | — | |
| Operating Lease Expense | — | — | — | — | — | — | — | — | — |
| Insider | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|
| KOZIN MARC D | Director | Aug 25 '26 | Sale | 304.50 | 7,000 | 2,131,476 | 21,112 | Aug 27 |
| Hudson Symeria | Director | Aug 18 '26 | Sale | 319.11 | 298 | 95,095 | 927 | Aug 19 |
| Hudson Symeria | Director | Aug 14 '26 | Sale | 324.58 | 1,926 | 625,141 | 1,225 | Aug 17 |
| FELDMANN CYNTHIA L | Director | Aug 13 '26 | Sale | 324.26 | 1,000 | 324,260 | 4,476 | Aug 17 |
| Hudson Symeria | Director | Aug 13 '26 | Option Exercise | 206.29 | 1,196 | 246,724 | 3,151 | Aug 17 |
| BAILLY R JEFFREY | Executive Chairman | Aug 10 '26 | Sale | 316.13 | 13,011 | 4,113,221 | 0 | Aug 11 |
| BAILLY R JEFFREY | Executive Chairman | Aug 07 '26 | Sale | 317.87 | 5,013 | 1,593,480 | 13,011 | Aug 10 |
| BAILLY R JEFFREY | Executive Chairman | Aug 06 '26 | Sale | 318.63 | 10,682 | 3,403,571 | 18,024 | Aug 10 |
| Holt Jason | Vice President | Aug 06 '26 | Sale | 317.00 | 1,100 | 348,700 | 7,878 | Aug 07 |
| FELDMANN CYNTHIA L | Director | Jun 12 '26 | Option Exercise | 43.95 | 1,200 | 52,740 | 6,676 | Jun 15 |
| FELDMANN CYNTHIA L | Director | Jun 12 '26 | Sale | 239.29 | 1,200 | 287,149 | 5,476 | Jun 15 |
| CROTEAU DANIEL C | Director | May 12 '26 | Sale | 221.71 | 2,864 | 634,977 | 855 | May 13 |
| CROTEAU DANIEL C | Director | May 08 '26 | Option Exercise | 22.02 | 2,864 | 63,065 | 3,719 | May 12 |
| OBERDORF THOMAS | Director | Mar 11 '26 | Option Exercise | 22.02 | 2,864 | 63,065 | 12,417 | Mar 12 |
| Holt Jason | Vice President | Dec 10 '25 | Sale | 213.58 | 100 | 21,358 | 7,678 | Dec 12 |